Growth Metrics

Omeros (OMER) Debt to Equity (2010 - 2026)

Omeros recorded quarterly Debt to Equity of -$0.83 in Q1 2026, down 47.73% quarter-over-quarter from -$0.56 in Q4 2025, and down 82.96% year-over-year from -$4.89 in Q1 2025.

Omeros' Debt to Equity history runs 17 years deep, the most recent figure standing at -$0.83 for Q1 2026.

  • In Q1 2026, Debt to Equity fell 82.96% year-over-year to -$0.83; the TTM figure through Mar 2026 stood at -$0.83 (down 82.96% YoY), while the FY2025 annual figure was -$0.56, down 13.71% from the prior year.
  • Debt to Equity came in at -$0.83 for Q1 2026 at Omeros, down from -$0.56 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $15.42 in Q2 2023 to a low of -$63.74 in Q1 2022.
  • A 5-year average of -$5.53 and a median of -$0.6 in 2024 frame the typical range for Debt to Equity.
  • Across the five-year window, Debt to Equity plunged 4431.89% in 2022 and soared 260.4% in 2023, its largest moves.
  • Omeros' Debt to Equity stood at $3.68 in 2022, then plunged by 331.87% to -$8.53 in 2023, then surged by 94.18% to -$0.5 in 2024, then decreased by 13.71% to -$0.56 in 2025, then plunged by 47.73% to -$0.83 in 2026.
  • According to Business Quant data, Debt to Equity over the past three periods registered -$0.83, -$0.56, and -$0.33 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.06
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn -0.83

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.83
Dec 31, 2025 -0.56
Sep 30, 2025 -0.33
Jun 30, 2025 -0.38
Mar 31, 2025 -0.46
Dec 31, 2024 -0.50
Sep 30, 2024 -0.60
Jun 30, 2024 -0.76
Mar 31, 2024 -2.99
Dec 31, 2023 -8.53
Sep 30, 2023 -22.70
Jun 30, 2023 15.42
Mar 31, 2023 5.75
Dec 31, 2022 3.68
Sep 30, 2022 -6.80
Jun 30, 2022 -9.61
Mar 31, 2022 -63.74
Dec 31, 2021 13.18
Sep 30, 2021 -1.19
Jun 30, 2021 -1.27
Mar 31, 2021 -1.41
Dec 31, 2020 -1.96
Sep 30, 2020 -2.67
Jun 30, 2020 -1.01
Mar 31, 2020 -1.22
Dec 31, 2019 -1.45
Sep 30, 2019 -1.11
Jun 30, 2019 -1.18
Mar 31, 2019 -1.27
Dec 31, 2018 -1.50
Sep 30, 2018 -1.49
Jun 30, 2018 -2.32
Mar 31, 2018 -2.93
Dec 31, 2017 -29.78
Sep 30, 2017 9.03
Jun 30, 2017 -1.49
Mar 31, 2017 -1.68
Dec 31, 2016 -2.13
Sep 30, 2016 -3.09
Jun 30, 2016 -1.43
Mar 31, 2016 -1.23
Dec 31, 2015 -1.90
Sep 30, 2015 -3.17
Jun 30, 2015 3.88
Mar 31, 2015 1.51
Dec 31, 2014 -0.76
Sep 30, 2014 -1.22
Jun 30, 2014 -3.05
Mar 31, 2014 6.18
Dec 31, 2013 -1.11
Sep 30, 2013 -0.85
Jun 30, 2013 -1.66
Mar 31, 2013 -1.27
Dec 31, 2012 -3.08
Sep 30, 2012 -10.58
Jun 30, 2012 -0.50
Mar 31, 2012 -0.94
Dec 31, 2011 -3.50
Sep 30, 2011 3.70
Jun 30, 2011 1.66
Dec 31, 2010 0.48